Bingjie Hu
6PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 15, 2025
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.Huiping Shuai, Jingxin Qiao, Chaemin Yoon
|Dec 11, 2025
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.Jialu Shi, Xiaoyu Zhao, Xiaohui Jin
|Jul 16, 2025
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.Huiping Shuai, Jingxin Qiao, Chaemin Yoon
|Nov 28, 2024
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.Hin Chu, Huiping Shuai, Jingxin Qiao
|Oct 08, 2024
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.Yuanchen Liu, Xiaoyu Zhao, Jialu Shi
|Jan 20, 2023
Altered host protease determinants for SARS-CoV-2 Omicron.Jasper Fuk-Woo Chan, Xiner Huang, Bingjie Hu
Pageof 1
Frequent Collaborators
6 joint publications
Jasper Fuk-Woo Chan
6 joint publications
Huiping Shuai
6 joint publications
Jie Zhou
6 joint publications
Hin Chu
5 joint publications
Kwok-Yung Yuen
3 joint publications
Chunfu Xu
3 joint publications
Zhen Fang
3 joint publications
Shengyong Yang
3 joint publications
Jian Lei
3 joint publications
Shuofeng Yuan
